Gan & Lee Pharmaceuticals.
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (24)
Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
Started: 1/22/2026
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Started: 9/23/2025
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Started: 10/17/2025
A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid
Started: 12/20/2024
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
Started: 4/7/2026
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Receiving Positive Airway Pressure (PAP) Therapy
Started: 3/27/2026
Evaluate the Efficacy and Safety of GZR18 Injection in Obese Subjects With Obstructive Sleep Apnea Not Treated With Positive Airway Pressure (PAP) Therapy
Started: 4/27/2026
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
Started: 2/17/2025
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Started: 1/16/2025
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
Started: 2/13/2025
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Obese/Overweight Subjects
Started: 12/30/2024
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin
Started: 2/18/2025
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Started: 2/15/2025
Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
Started: 4/10/2026
A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus
Started: 8/7/2025
Bioequivalence Study of GZR18 Injection Before and After CMC Change
Started: 1/9/2026
Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
Started: 11/17/2025
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Renal Impairment and Normal Renal Function
Started: 4/11/2025
Study of Pharmacokinetics and Safety of GZR18 Injection in Subjects With Liver Insufficiency and Normal Liver Function
Started: 8/12/2025
A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
Started: 4/30/2026
A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects
Started: 3/9/2026
Pharmacokinetic and Safety Study of GZR4 Injection in Subjects With Hepatic Impairment
Started: 10/20/2025
A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
Started: 5/8/2025